poisar

Stocks · News reference

Rocket Lab Rallies as SpaceX Slides. Wall Street Is Rewarding Execution Again

BenzingaJul 27, 2026, 7:17 PMSurbhi Jain

Rocket Lab gained after landing a $266 million Space Force contract while SpaceX shares extended their post-IPO decline.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 27, 2026, 7:17 PM
Checked
Jul 27, 2026, 7:17 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley FoolAug 26, 2026, 7:05 AMCourtney Carlsen

    Peter Beck's Neutron Rocket Could Slip to 2027. Here's How Much the Delay Actually Matters.

    Rocket Lab's Neutron rocket launch has been delayed from 2026 to a likely 2027 timeframe following a Stage 1 propellant tank rupture during a January pressure test. CEO Peter Beck emphasizes prioritizing readiness and long-term production over meeting short-term deadlines. The company expects adjusted EBITDA to turn positive once Neutron begins flying, positioning it to compete with SpaceX for larger, more lucrative contracts.

    Read original at the-motley-fool
  2. The Motley FoolAug 27, 2026, 7:37 PMBrendan Coffey

    Archer Aviation vs. Space Exploration Technologies: Which High Flying Stock Is a Better Buy in 2026?

    Archer Aviation and SpaceX represent two different aerospace plays with vastly different maturity levels. Archer is pre-commercial with $300K revenue and $618M losses, pursuing FAA certification for eVTOL aircraft. SpaceX generates $18.7B in revenue but reported a $5B net loss in FY2025 due to massive capital requirements. The article concludes SpaceX is the wiser long-term choice despite both companies' negative cash flows, citing SpaceX's established Starlink business and market support versus Archer's high valuation multiples and regulatory uncertainties.

    Read original at the-motley-fool